| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776839 | The Breast | 2018 | 6 Pages |
Abstract
Among hormone receptor-negative patients, delaying chemotherapy initiation beyond 6 weeks (after surgery) is associated with worse patient outcomes. Moreover, delaying radiotherapy initiation beyond surgery does not compromise outcomes in patients receiving long course adjuvant chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Omar Abdel-Rahman,